×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
The top documents tagged [asco annual meetingdisclosure]
Efficacy and Safety of Continued Zoledronic Acid every 4 Weeks versus every 12 Weeks in Women with Bone Metastases from Breast Cancer: Results of the OPTIMIZE-2
218 views
Bevacizumab may Differentially Improve Survival for Patients with the Proliferative and Mesenchymal Molecular Subtype of Ovarian Cancer Presented By Boris
217 views
Presented By Gabriel Hortobagyi at 2014 ASCO Annual Meeting
60 views
Presented By Boris Winterhoff at 2014 ASCO Annual Meeting
83 views